Literature DB >> 18785217

Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.

Andrea C Solomon1, Julie C Stout, Marjorie Weaver, Sarah Queller, Allison Tomusk, Kathryn Burr Whitlock, Siu L Hui, Jeanine Marshall, Jacqueline Gray Jackson, Eric R Siemers, Xabier Beristain, Joanne Wojcieszek, Tatiana Foroud.   

Abstract

Longitudinal studies of neurocognitive function in prediagnosis Huntington disease (pre-HD) have been few, and duration of follow-up has been brief. In this study, 155 individuals at-risk for HD completed a battery of cognitive and motor tasks at two study visits approximately 10 years apart. Participants were classified as: (1) at-risk, without the CAG expansion (healthy controls, NC; n = 112), or (2) CAG expanded (CAG+; n = 43). To examine the rate of decline at different stages of the pre-HD period, participants in the CAG+ group were further characterized as converters (i.e., individuals who developed manifest HD over the course of the study; n = 21) or nonconverters (n = 22), and their performances were compared. The CAG+ group exhibited faster rates of neurocognitive decline over the course of the study, relative to the NC group. In addition, more rapid decline was associated with closer proximity to estimated age of disease onset in the CAG+ group. Faster rates of motor and psychomotor decline were observed in the CAG+ converter group, relative to the nonconverters. These findings suggest that neurocognitive decline in pre-HD, particularly in motor and psychomotor domains, begins insidiously and accelerates as individuals approach disease onset. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18785217      PMCID: PMC2592091          DOI: 10.1002/mds.22097

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Direct amplification of the CAG repeat of huntingtin without amplification of CCG.

Authors:  C E Bond; M E Hodes
Journal:  Clin Chem       Date:  1996-05       Impact factor: 8.327

2.  Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals.

Authors:  Jason Brandt; Barnett Shpritz; Ann Marie Codori; Russell Margolis; Adam Rosenblatt
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

3.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.

Authors:  S C Kirkwood; E Siemers; C Bond; P M Conneally; J C Christian; T Foroud
Journal:  Arch Neurol       Date:  2000-07

5.  Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.

Authors:  J B Penney; A B Young; I Shoulson; S Starosta-Rubenstein; S R Snodgrass; J Sanchez-Ramos; M Ramos-Arroyo; F Gomez; G Penchaszadeh; J Alvir
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

6.  Subtle changes among presymptomatic carriers of the Huntington's disease gene.

Authors:  S C Kirkwood; E Siemers; M E Hodes; P M Conneally; J C Christian; T Foroud
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

7.  Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year.

Authors:  J Lemiere; M Decruyenaere; G Evers-Kiebooms; E Vandenbussche; R Dom
Journal:  Acta Neurol Scand       Date:  2002-09       Impact factor: 3.209

8.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

9.  Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease.

Authors:  Shannon A Johnson; Julie C Stout; Andrea C Solomon; Douglas R Langbehn; Elizabeth H Aylward; Christina B Cruce; Christopher A Ross; Martha Nance; Elise Kayson; Elaine Julian-Baros; Michael R Hayden; Karl Kieburtz; Mark Guttman; David Oakes; Ira Shoulson; Leigh Beglinger; Kevin Duff; Elizabeth Penziner; Jane S Paulsen
Journal:  Brain       Date:  2007-07       Impact factor: 13.501

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  26 in total

1.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

2.  Tracking motor impairments in the progression of Huntington's disease.

Authors:  Jeffery D Long; Jane S Paulsen; Karen Marder; Ying Zhang; Ji-In Kim; James A Mills
Journal:  Mov Disord       Date:  2013-10-21       Impact factor: 10.338

Review 3.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

4.  Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.

Authors:  Eve M Dumas; Simon J A van den Bogaard; Margot E Ruber; Ralf R Reilman; Julie C Stout; David Craufurd; Stephen L Hicks; Chris Kennard; Sarah J Tabrizi; Mark A van Buchem; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2011-01-24       Impact factor: 5.038

5.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

6.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

7.  Monitoring Huntington's disease progression through preclinical and early stages.

Authors:  Chris Tang; Andrew Feigin
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

8.  Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year period.

Authors:  Sarah L Mason; Ruwani Wijeyekoon; Rachel Swain; Aileen K Ho; Emma L Smith; Barbara Sahakian; Roger A Barker
Journal:  PLoS Curr       Date:  2010-09-02

9.  Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Leigh J Beglinger; Kevin Duff; Jessica Allison; Danielle Theriault; Justin J F O'Rourke; Anne Leserman; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2009-10-29       Impact factor: 2.475

10.  Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.

Authors:  Robert Christian Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine Donata Wolf; Philipp Arthur Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth
Journal:  Hum Brain Mapp       Date:  2011-08-25       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.